These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 7504442)
1. Human urinary trypsin inhibitor, urinastatin, prevents pancreatic injuries induced by pancreaticobiliary duct obstruction with cerulein stimulation and systemic hypotension in the rat. Hirano T; Manabe T Arch Surg; 1993 Dec; 128(12):1322-9; discussion 1329. PubMed ID: 7504442 [TBL] [Abstract][Full Text] [Related]
2. Effect of urinary trypsin inhibitor on pancreatic cellular and lysosomal fragility in cerulein-induced acute pancreatitis in rats. Hirano T; Manabe T; Tobe T Dig Dis Sci; 1993 Apr; 38(4):660-4. PubMed ID: 7681748 [TBL] [Abstract][Full Text] [Related]
3. A possible mechanism for gallstone pancreatitis: repeated short-term pancreaticobiliary duct obstruction with exocrine stimulation in rats. Hirano T; Manabe T Proc Soc Exp Biol Med; 1993 Feb; 202(2):246-52. PubMed ID: 7678705 [TBL] [Abstract][Full Text] [Related]
4. The protective effect of the trypsin inhibitor urinastatin on cerulein-induced acute pancreatitis in rats. Tani S; Otsuki M; Itoh H; Nakamura T; Fujii M; Okabayashi Y; Fujisawa T; Baba S Pancreas; 1988; 3(4):471-6. PubMed ID: 2459695 [TBL] [Abstract][Full Text] [Related]
5. A new experimental model for gallstone pancreatitis: short-termed pancreatico-biliary duct obstruction and exocrine stimulation with systemic hypotension in rats. Hirano T; Manabe T Nihon Geka Hokan; 1993 Jan; 62(1):3-15. PubMed ID: 8352638 [TBL] [Abstract][Full Text] [Related]
6. Protective effects of prophylaxis with a protease inhibitor and a free radical scavenger against a temporary ischemia model of pancreatitis. Hirano T; Furuyama H; Kawakami Y; Ando K; Tsuchitani T Can J Surg; 1995 Jun; 38(3):241-8. PubMed ID: 7540502 [TBL] [Abstract][Full Text] [Related]
7. Effect of short-termed pancreatic duct obstruction on the pancreatic subcellular organellar fragility and pancreatic lysosomal enzyme secretion in rabbits. Hirano T; Manabe T Scand J Clin Lab Invest; 1992 Oct; 52(6):523-35. PubMed ID: 1384108 [TBL] [Abstract][Full Text] [Related]
8. Cytoprotective effects of prostaglandins and a new potent protease inhibitor in acute pancreatitis. Hirano T; Manabe T; Tobe T Am J Med Sci; 1992 Sep; 304(3):154-63. PubMed ID: 1282294 [TBL] [Abstract][Full Text] [Related]
9. Protective effects of therapy with a protease and xanthine oxidase inhibitor in short form pancreatic biliary obstruction and ischemia in rats. Hirano T; Manabe T; Steer M; Printz H; Calne R; Tobe T Surg Gynecol Obstet; 1993 Apr; 176(4):371-81. PubMed ID: 8460415 [TBL] [Abstract][Full Text] [Related]
10. The protective effects of long-acting recombinant human pancreatic secretory trypsin inhibitor (R44S-PSTI) in a rat model of cerulein-induced pancreatitis. Chen YZ; Ikei S; Yamaguchi Y; Sameshima H; Sugita H; Moriyasu M; Ogawa M J Int Med Res; 1996; 24(1):59-68. PubMed ID: 8674801 [TBL] [Abstract][Full Text] [Related]
11. Intracellular action of an exogenous low-molecular-weight synthetic protease inhibitor, E3123, in cerulein-induced acute pancreatitis in rats. Sata N; Atomi Y; Kimura W; Kuroda A; Muto T; Mineo C Int J Pancreatol; 1994 Apr; 15(2):119-27. PubMed ID: 8071570 [TBL] [Abstract][Full Text] [Related]
12. Thromboxane A2 receptor antagonist prevents pancreatic microvascular leakage in rats with caerulein-induced acute pancreatitis. Hirano T; Hirano K Int J Surg Investig; 1999; 1(3):203-10. PubMed ID: 11341608 [TBL] [Abstract][Full Text] [Related]
13. Activation of proteases in cerulein-induced pancreatitis. Yamaguchi H; Kimura T; Mimura K; Nawata H Pancreas; 1989; 4(5):565-71. PubMed ID: 2478999 [TBL] [Abstract][Full Text] [Related]
15. Peptide leukotriene receptor antagonist diminishes pancreatic edema formation in rats with cerulein-induced acute pancreatitis. Hirano T Scand J Gastroenterol; 1997 Jan; 32(1):84-8. PubMed ID: 9018772 [TBL] [Abstract][Full Text] [Related]
16. Experimental acute pancreatitis induced by excessive doses of caerulein in rats; protective and therapeutic effects of trypsin inhibitor urinastatin and CCK receptor antagonist CR1392. Tani S Kobe J Med Sci; 1988 Apr; 34(2):93-112. PubMed ID: 3216603 [No Abstract] [Full Text] [Related]
17. Pancreatic and bile duct obstruction exacerbates rat caerulein-induced pancreatitis: a new experimental model of acute hemorrhagic pancreatitis. Yamasaki M; Takeyama Y; Shinkai M; Ohyanagi H J Gastroenterol; 2006 Apr; 41(4):352-60. PubMed ID: 16741615 [TBL] [Abstract][Full Text] [Related]
18. Cerulein-induced in vitro activation of trypsinogen in rat pancreatic acini is mediated by cathepsin B. Saluja AK; Donovan EA; Yamanaka K; Yamaguchi Y; Hofbauer B; Steer ML Gastroenterology; 1997 Jul; 113(1):304-10. PubMed ID: 9207291 [TBL] [Abstract][Full Text] [Related]
19. Cellular alterations of parotid gland of rats with acute pancreatitis induced by cerulein. Hirano T; Manabe T; Tobe T Int J Pancreatol; 1991; 10(3-4):217-27. PubMed ID: 1724007 [TBL] [Abstract][Full Text] [Related]
20. [The cellular and lysosomal fragility of pancreatic acinar cells after ligation of pancreatico-biliary duct in the rat and the protective effects of nafamostat mesilate]. Hirano T; Manabe T; Tobe T Nihon Geka Gakkai Zasshi; 1992 Dec; 93(12):1489-500. PubMed ID: 1283776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]